Skip to main content

Table 2 EQD2 dose received by 0.1 cc OARs

From: Comparative study to evaluate dosimetric differences in patients of locally advanced carcinoma cervix undergoing intracavitary brachytherapy under two different anaesthesia techniques: an audit from a tertiary cancer centre in India

Organs at risk Group N Mean Std. deviation Min Max p value 95% CI of the difference
Lower Upper
Sigmoid colon GA 16 75.4331 18.30633 52.28 122.12 .924 − 10.37846 11.40576
PS 19 74.9195 13.30924 53.13 98.84
Bladder GA 16 105.1681 17.58910 63.65 127.09 .537 − 11.14112 21.00263
PS 19 100.2374 27.12735 60.4 172.49
Rectum GA 16 72.6000 9.23701 55.14 88.30 .009* − 19.07379 − 2.92621
PS 19 83.6000 13.40413 60.58 118.62
  1. * p-values are significant at 5% level of significance